MBIO – mustang bio, inc. (US:NASDAQ)
Stock Stats
News
Blastic Plasmacytoid Dendritic Cell Neoplasm Market Research and Forecast Report 2025-2035: CD123-Targeted Therapies Emerge as the Leading Opportunity, Driven by ADCs, CAR-T, Bispecific Development [Yahoo! Finance]
Mustang Bio (NASDAQ:MBIO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form SCHEDULE 13D/A MUSTANG BIO, INC. Filed by: Fortress Biotech, Inc.
Form 4 MUSTANG BIO, INC. For: Jan 02 Filed by: Fortress Biotech, Inc.
Form 4 MUSTANG BIO, INC. For: Dec 30 Filed by: Herskowitz Neil
Form 4 MUSTANG BIO, INC. For: Dec 30 Filed by: Chill Adam J.
Form 4 MUSTANG BIO, INC. For: Dec 30 Filed by: Jin David
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.